Table 1 Patient characteristics and comorbidities: elevated RVSP group versus normal RVSP group
Elevated RVSP n = 42 | Normal RVSP n = 56 | P value | |
|---|---|---|---|
Baseline characteristics | |||
Age, years, median, (IQR) | 83 (75,89) | 77 (68,85) | 0.040 |
Male, no. (%) | 14 (33%) | 26 (46%) | 0.196 |
ASA status | |||
ASA class 4, no. (%) | 11 (26%) | 10 (18%) | 0.342 |
Comorbidities | |||
Cardiac disease | |||
Heart failure, no. (%) | 11 (26%) | 7 (12%) | 0.075 |
Ischemic heart disease, no (%) | 17 (40%) | 15 (27%) | 0.176 |
Valve replacement, no. (%) | 3 (7%) | 4 (7%) | 1.000 |
Atrial fibrillation, no. (%) | 19 (45%) | 12 (21%) | 0.011 |
Pulmonary hypertension, no. (%) | 4 (9%) | 0 (0%) | 0.022 |
Respiratory disease | |||
COPD, no. (%) | 13 (30%) | 8 (14%) | 0.054 |
Smoking, no. (%) | 6 (14%) | 7 (12%) | 0.770 |
Obstructive sleep apnea, no. (%) | 2 (5%) | 2 (3%) | 0.612 |
Asthma, no. (%) | 3 (7%) | 3 (5%) | 0.678 |
Bronchiectasis, no. (%) | 2 (5%) | 0 (0%) | 0.092 |
Vascular disease | |||
Hypertension, no. (%) | 20 (48%) | 27 (48%) | 1.000 |
Cerebrovascular disease / Transient ischemic attack, mo. (%) | 7 (17%) | 12 (21%) | 0.621 |
Peripheral vascular disease / venous ulcers, no. (%) | 1 (2%) | 7 (12%) | 0.067 |
Abdominal aortic aneurysm, no. (%) | 3 (7%) | 3 (5%) | 0.678 |
Thromboembolic disease | |||
Deep vein thrombosis / pulmonary embolism, no. (%) | 4 (9%) | 5 (9%) | 1.000 |
Renal disease | |||
Chronic kidney disease, no. (%) | 9 (21%) | 8 (14%) | 0.363 |
Dialysis dependence, no. (%) | 1 (2%) | 2 (4%) | 0.576 |